EGFR and lung cancer: Oncogenic driver mutations are present in over 50% of lung cancer, including mutations in EGFR, KRAS, BRAF, PI3K, MEK-1, HER2, MET, ALK and RET and inactivation of tumour suppressor genes (such as P53, PTEN, LKB-1) (reviewed in [112]).